A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline
NCT ID: NCT01889771
Last Updated: 2016-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1495 participants
INTERVENTIONAL
2010-03-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Providing Free Nicotine Patches to Quitline Smokers
NCT01736085
Long-term Effectiveness of Mailed Nicotine Replacement Therapy: A 5-year Follow-up
NCT03097445
Offering Nicotine Patches to All Households in a Municipality With High Smoking Rates
NCT04534231
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034
e-Cigarettes Versus NRT Gum for Smoking Cessation
NCT01925781
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nicotine Patch (4 weeks)
participants receive one 4-weeks supply of nicotine patches
Nicotine Patch
nicoderm patches are distributed in two different supplies through a telephone quitline
Nicotine Patch (8 weeks)
participants receive up to 8 weeks of nicotine patches in up to two 4-week supplies
Nicotine Patch
nicoderm patches are distributed in two different supplies through a telephone quitline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicotine Patch
nicoderm patches are distributed in two different supplies through a telephone quitline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* who enroll in QuitLine services
* who do not require physician approval to obtain nicotine replacement therapy
* who are willing to receive the nicotine patch
Exclusion Criteria
* those who do not complete the call in English
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily K Burns
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
References
Explore related publications, articles, or registry entries linked to this study.
Theodoulou A, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J, Livingstone-Banks J, Hajizadeh A, Lindson N. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2023 Jun 19;6(6):CD013308. doi: 10.1002/14651858.CD013308.pub2.
Burns EK, Hood NE, Goforth E, Levinson AH. Randomised trial of two nicotine patch protocols distributed through a state quitline. Tob Control. 2016 Mar;25(2):218-23. doi: 10.1136/tobaccocontrol-2014-051843. Epub 2014 Nov 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-0757
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.